"Weight-Loss Drug Zepbound Faces Shortages and Backorders at Rite Aid, Amazon, and Eli Lilly"

TL;DR
Eli Lilly & Co. acknowledges potential difficulties in obtaining its weight loss drug Zepbound due to high demand, with reports of backorders and delays at pharmacies across the US, prompting concerns about shortages.
Want the full story? Read the original reporting
Read on Bloomberg